BRITTANY SHAW: Open Payments
NPI 1073905923 · FLOWOOD, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,082 in 67 payments from 16 companies in 2025. Trend: 2023 $656 · 2024 $311 · 2025 $1,082
Food & beverage: $1,082
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 12 | $247 |
| Novo Nordisk Inc | 13 | $199 |
| ABBVIE INC. | 9 | $147 |
| GlaxoSmithKline, LLC. | 13 | $142 |
| Lilly USA, LLC | 8 | $134 |
| Esperion Therapeutics, Inc. | 2 | $33 |
| SANOFI PASTEUR INC. | 1 | $30 |
| ABIOMED | 1 | $25 |
| Inspire Medical Systems, Inc. | 1 | $24 |
| Merck Sharp & Dohme LLC | 1 | $19 |
Products named: PREVNAR 20, TRELEGY ELLIPTA, MOUNJARO, Ozempic, UBRELVY, Rybelsus, ELIQUIS, KISUNLA.
Industry payments across MS — which companies pay providers there.
